SEC Filing Summary: Form 8-K
Business Context and Reporting Period
Company: Avista Healthcare Public Acquisition Corp. (AHPAC), a Cayman Islands exempted company and emerging growth company.
Date of Report: November 22, 2017.
Context: This filing reports an amendment to a previously disclosed Transaction Agreement regarding a proposed Business Combination between AHPAC and Envigo International Holdings, Inc. (Envigo). The filing serves as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
Key Financial Metrics
The filing text does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on the legal amendment to a merger agreement and does not contain financial statements or operational data for the reporting period.
Material Changes
On November 22, 2017, AHPAC, its subsidiaries, and Envigo entered into an amendment to the Transaction Agreement originally signed on August 21, 2017. The material changes include:
- Termination Date Extension: The Termination Date for the transaction was extended from January 31, 2018, to March 31, 2018.
- NASDAQ Compliance Waiver: The amendment stipulates that any notice of non-compliance from NASDAQ related to AHPAC's failure to hold an annual meeting in 2017 shall not constitute a failure to satisfy conditions for the consummation of the Business Combination.
Outlook, Risks, and Management Commentary
Outlook and Process: AHPAC has filed a preliminary proxy statement and intends to file and mail a definitive proxy statement to shareholders. Shareholders will be asked to vote on the proposed Business Combination once a record date is established.
Risks and Contingencies: The filing includes a standard disclaimer stating that the report does not constitute an offer to sell or a solicitation of an offer to buy securities in jurisdictions where such actions would be unlawful. The transaction remains subject to the terms of the Transaction Agreement and the approval of shareholders.
Participants: AHPAC's directors, executive officers, and management are deemed participants in the solicitation of proxies. Detailed information regarding these participants is contained in the preliminary and definitive proxy statements.
Investor Verification Checklist
- Verify the full text of the Amendment No. 1 to the Transaction Agreement (Exhibit 2.1) for any additional terms not summarized in this 8-K.
- Review the preliminary and definitive proxy statements for detailed financial information regarding Envigo and the combined entity.
- Confirm the record date for shareholder voting on the Business Combination once established.
- Monitor NASDAQ compliance status regarding the 2017 annual meeting to ensure no other conditions are triggered.
- Check for any subsequent filings that may update the status of the Business Combination or the Termination Date.